Sue is President and CEO of AGTC, a clinical-stage biotechnology company that uses its proprietary gene therapy platform to develop products designed to transform the lives of patients with severe diseases, with an initial focus in ophthalmology. AGTC uses cutting-edge techniques to offer hope to patients with rare diseases and unmet medical needs.
agtc.com
Sue Washer, MBA '92
President & CEO
Biotechnology
Alachua, FL